Overview
- 38 inspections across 33 sites are on record.
- 88 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-07-17.
At a glance
Inspections
38
Sites
33
Observations
88
Career since
Mar 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Hieber's Pharmacy | 17 Jul 2019 | Human Drugs | On file |
| Apozeal Pharmaceuticals Inc. | 9 Apr 2019 | Human Drugs | View 483 → |
| SGS Life Science Services North America Inc | 17 Jan 2019 | Human Drugs | |
| Altasciences CDMO Philadelphia | 17 Dec 2018 | Human Drugs | |
| Apozeal Pharmaceuticals Inc. | 9 Nov 2018 | Human Drugs |
Sites inspected
Hieber's PharmacyPittsburgh, United States1 insp.
Apozeal Pharmaceuticals Inc.Levittown, United States2 insp.
SGS Life Science Services North America IncWest Chester, United States1 insp.
Altasciences CDMO PhiladelphiaHarleysville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Gayle S Lawson5 shared
Christina K Theodorou4 shared
Matthew R Noonan4 shared
James M Mason4 shared
Freddy Ortiz Colon2 shared
Anita R Michael2 shared
Kyle S Hobson2 shared
Joseph L Despins2 shared
Daniel W Johnson2 shared
Dandan Wang1 shared
Full investigator report
Get the verbatim findings behind Lisa B Orr's 88 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site